BioNTech SE - ADR vs Ross Stores, Inc. — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Ross Stores, Inc. trades at $251.3 (market cap $80.78B). The key difference: Ross Stores, Inc. is far larger — about 3.5× BioNTech SE - ADR's market cap, and Ross Stores, Inc. pays a 0.71% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | ROST | |
|---|---|---|
Market Cap | $23.31B | $80.78B |
Sector | Health | Consumer Cyclical |
52-Week High | $119.34 | $255.23 |
52-Week Low | $83.89 | $144.67 |
Enterprise Value | $6.60B | $81.37B |
Dividend Yield | — | 0.71% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →